SALL4: An Intriguing Therapeutic Target in Cancer Treatment
Open accessThe DOI matches its Crossref record; 107 of the 116 references it cites were found in a registry or an index.
Abstract
Spalt-Like Transcription Factor 4 (SALL4) is a critical factor for self-renewal ability and pluripotency of stem cells. On the other hand, various reports show tight relation of SALL4 to cancer occurrence and metastasis. SALL4 exerts its effects not only by inducing gene expression but also repressing a large cluster of genes through interaction with various epigenetic modifiers. Due to high expression of SALL4 in cancer cells and its silence in almost all adult tissues, it is an ideal target for cancer therapy. However, targeting SALL4 meets various challenges. SALL4 is a transcription factor and designing appropriate drug to inhibit this intra-nucleus component is challenging. On the other hand, due to lack of our knowledge on structure of the protein and the suitable active sites, it becomes more difficult to reach the appropriate drugs against SALL4. In this review, we have focused on approaches applied yet to target this oncogene and discuss the potential of degrader systems as new therapeutics to target oncogenes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a transcription factor, the uniqueness of SALL4 lies in the fact that it is expressed in embryonic cells, downregulated during development, absent in most adult tissues, and re-expressed in a significant fraction of almost all human adult tumors (Moein et al, 2022; Tatetsu et al, 2016).”
From Targeting transcription factors through an IMiD independent zinc finger domain (2025) · cites this paper as Moein et al, 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a transcription factor, the uniqueness of SALL4 lies in the fact that it is expressed in embryonic cells, downregulated during development, absent in most adult tissues, and re-expressed in a significant fraction of almost all human adult tumors (Moein et al, 2022; Tatetsu et al, 2016).”
From Targeting transcription factors through an IMiD independent zinc finger domain (2025) · cites this paper as Moein et al, 2022
The cited source says what the claim attributes to it.
In the citing paper
“there is some evidence that it may act as an oncogene 68”
From Tetramerisation governs SALL transcription factor function in development and disease (2025) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4
Zhou, W., Zou, B., Liu, L., Cui, K., Gao, J., Yuan, S., & Cong, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12190 · Cited by 59
RetractedXia, Z., Qiu, D., Deng, J., Jiao, X., Yang, R., Sun, Z., Wan, X. H., & Li, J. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3464 · Cited by 12
RetractedVillanueva, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1713263 · Cited by 4,508
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273 · cited 1×
“Oligomycin is a macrolide produced by Streptomyces and an inhibitor of adenosine triphosphate (ATP) synthase [90].”
BackgroundDefining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Sievers, Q. L., Petzold, G., Bunker, R. D., Renneville, A., Słabicki, M., Liddicoat, B. J., Abdulrahman, W., Mikkelsen, T., Ebert, B. L., & Thomä, N. H. (2018) · Science · doi:10.1126/science.aat0572 · Cited by 537 · cited 4×
“Thalidomide as an ImiD, promotes ubiquitination and subsequent degradation of SALL4A on ZFC2 C2H2 domains by binding to Cereblon (CRBN) in the choline complex E3 ubiquitin ligase Cells 2022, 11, 2601 11 of 15 (CRL4CRBN) [105].”
BackgroundInfluentialDonovan, K. A., An, J., Nowak, R. P., Yuan, J. C., Fink, E. C., Berry, B. C., Ebert, B. L., & Fischer, E. S. (2018) · eLife · doi:10.7554/elife.38430 · Cited by 509
The LIN28/let-7 Pathway in Cancer
Balzeau, J., Menezes, M. R., Cao, S., & Hagan, J. P. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00031 · Cited by 447
The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
Dimri, G. P., Martínez‐Guitarte, J., Jacobs, J. J. L., Keblusek, P., Itahana, K., van Lohuizen, M., Campisi, J., Wazer, D. E., & Band, V. (2002) · PubMed · Cited by 396
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
Qi, S.-M., Dong, J., Xu, Z.-Y., Cheng, X.-D., Zhang, W.-D., & Qin, J.-J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.692574 · Cited by 292 · cited 1×
“For a while, lack of structure knowledge on suitable active or binding sites, localization of the protein in the nucleus, and inaccessibility on the cell surface all make SALL4 as a critical choice for therapeutic drug design [86].”
BackgroundOncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Yong, K. J., Gao, C., Lim, J. S. J., Yan, B., Yang, H., Dimitrov, T., Kawasaki, A., Ong, C. W., Wong, K.-F., Lee, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300297 · Cited by 257 · cited 4×
“The prognostic value of SALL4 in primary HCC also is determined in our previous study [58].”
BackgroundResultSelf-citationKühnlein, R. P., Frommer, G., Friedrich, M., Gonzalez-Gaitan, M., Weber, A., Wagner-Bernholz, J. F., Gehring, W. J., Jäckle, H., & Schuh, R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06246.x · Cited by 248 · cited 1×
“The SALL4 protein contains several zinc finger cluster (ZFC) domains spread in different parts of the protein which give it both transcription activation and repression functions [7,8].”
BackgroundLim, C. Y., Tam, W.-L., Zhang, J., Ang, H. S., Jia, H., Lipovich, L., Ng, H.-H., Wei, C.-L., Sung, W. K., Robson, P., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.004 · Cited by 224 · cited 2×
“Moreover, there is an interconnected regulatory loop constituted of SALL4, OCT4, NANOG, and SOX2 that each transcription factor regulates both its own expression as well as the other genes in the loop [13,24].”
BackgroundMa, Y., Cui, W., Yang, J., Qu, J., Di, C., Amin, H. M., Lai, R., Ritz, J., Krause, D. S., & Chai, L. (2006) · Blood · doi:10.1182/blood-2006-02-001594 · Cited by 215 · cited 1×
“Our findings showed that the level of SALL4 expression is positively correlated with karyotype abnormalities, poor survival, and an increased risk of MDS to AML transformation [39,40].”
BackgroundSelf-citationMiettinen, M., Wang, Z., McCue, P. A., Sarlomo-Rikala, M., Rys, J., Biernat, W., Lasota, J., & Lee, Y.-S. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000116 · Cited by 204 · cited 1×
“However, the gene is silenced in most of the adult tissues except germ cells and CD34+ hematopoietic stem cells [4,5].”
BackgroundYang, J., Chai, L., Fowles, T. C., Alipio, Z., Xu, D., Fink, L. M., Ward, D. C., & Ma, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809321105 · Cited by 202 · cited 1×
“3223 genes were determined as potential target genes of SALL4 among which genes related to Nuclear Factor Kappa-light-chain-enhancer of activated B cells (NFKB), apoptosis, Platelet-Derived Growth Factor (PDGF), P53, Transforming Growth Factor Beta (TGFB), and Wnt/B-catenin were enriched [23].”
BackgroundSelf-citationSal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
Oikawa, T., Kamiya, A., Zeniya, M., Chikada, H., Hyuck, A. D., Yamazaki, Y., Wauthier, E., Tajiri, H., Miller, L. D., Wang, X. W., et al. (2013) · Hepatology · doi:10.1002/hep.26159 · Cited by 195 · cited 2×
“SALL4 as a cancer stem cell related gene, is suggested as a valuable prognostic biomarker for classification of progenitor-like HCC subtypes [58,59].”
BackgroundMurine inner cell mass-derived lineages depend on Sall4 function
Elling, U., Klasen, C., Eisenberger, T., Anlag, K., & Treier, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607884103 · Cited by 186 · cited 1×
“In the blastocyst SALL4 over expression is observed in the inner cell mass (ICM) and the trophectoderm and later in midbrain, genital tubercle, limb, and tail buds [1].”
BackgroundOligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis
Shchepina, L. A., Pletjushkina, O. Y., Avetisyan, A. V., Bakeeva, L. E., Fetisova, E. K., Izyumov, D. S., Saprunova, V. B., Vyssokikh, M. Y., Chernyak, B. V., & Skulachev, V. P. (2002) · Oncogene · doi:10.1038/sj.onc.1206053 · Cited by 170 · cited 2×
“Although glycolysis was previously thought to be the major energy producer of cancer cells, recent findings highlight the critical role of oxidative phosphorylation mechanisms in promotion of tumor progression [89].”
BackgroundLu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005577 · Cited by 168 · cited 1×
“Phosphatase and tensin homolog (PTEN) that is an important tumor suppressor gene and blocks Phosphatidylinositol-3-Kinase/Protein Kinase B signaling (PI3K/AKT) is a downstream target of SALL4 [19,20].”
BackgroundSelf-citationAptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Fu, Z., & Xiang, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082793 · Cited by 153 · cited 1×
“Aptamers are a class of synthesized RNA or DNA oligonucleotides which by their three-dimensional structure specifically bind to target molecules [103].”
BackgroundA Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells
Yang, J., Gao, C., Chai, L., & Ma, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010766 · Cited by 152 · cited 1×
“Moreover, there is an interconnected regulatory loop constituted of SALL4, OCT4, NANOG, and SOX2 that each transcription factor regulates both its own expression as well as the other genes in the loop [13,24].”
BackgroundSelf-citationThe transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140 · cited 1×
“Spheroid formation, invasion and drug-resistance all are associated with augmented levels of SALL4 in HCC [58,60,61].”
BackgroundMicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1
Lin, Y., Liu, A. Y., Fan, C., Zheng, H., Li, Y., Zhang, C., Wu, S., Yu, D., Huang, Z., Liu, F., et al. (2015) · Scientific Reports · doi:10.1038/srep09995 · Cited by 140 · cited 3×
“miR-33b has a binding site in 3′ untranslated region (UTR) of the SALL4 mRNA and inhibits it in breast cancer cells [28].”
BackgroundInfluentialBmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells
Yang, J., Chai, L., Liu, F., Fink, L. M., Lin, P., Silberstein, L. E., Amin, H. M., Ward, D. C., & Ma, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704001104 · Cited by 134
Self-citationFujii, Y., Yoshihashi, K., Suzuki, H., Tsutsumi, S., Mutoh, H., Maeda, S., Yamagata, Y., Seto, Y., Aburatani, H., & Hatakeyama, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208651109 · Cited by 134 · cited 2×
“It is shown that Signal Transducer and Activator of Transcription 3 (STAT3) and caudal type homeobox 1 (CDX1) promote SALL4 expression in breast and gastric cancers, respectively [11,12].”
BackgroundSALL4 is a key regulator of survival and apoptosis in human leukemic cells
Yang, J., Chai, L., Gao, C., Fowles, T. C., Alipio, Z., Dang, H., Xu, D., Fink, L. M., Ward, D. C., & Ma, Y. (2008) · Blood · doi:10.1182/blood-2007-11-126326 · Cited by 132 · cited 1×
“Chip-chip assay and subsequent gene set enrichment analysis on NB4 leukemic cells demonstrated that SALL4 regulates pathways related to apoptosis, proliferation, inflammation, and cell cycle arrest [45].”
MethodSelf-citationSALL4, the missing link between stem cells, development and cancer
Tatetsu, H., Kong, N. R., Chong, G., Amabile, G., Tenen, D. G., & Chai, L. (2016) · Gene · doi:10.1016/j.gene.2016.02.019 · Cited by 130 · cited 3×
“SALL4A has one C2HC domain at N-terminal, one double C2H2 (ZFC4) at C-terminal and one double C2H2 (ZFC2) and one triple C2H2 (ZFC3) at the middle of the protein.”
BackgroundSelf-citationKohlhase, J., Chitayat, D., Kotzot, D., Ceylaner, S., Froster, U. G., Fuchs, S., Montgomery, T., & Rösler, B. (2005) · Human Mutation · doi:10.1002/humu.20215 · Cited by 119
Ashrafizadeh, M., Hushmandi, K., Moghadam, E. R., Zarrin, V., Kashani, S. H., Bokaie, S., Najafi, M., Tavakol, S., Mohammadinejad, R., Nabavi, N., et al. (2020) · Bioengineering · doi:10.3390/bioengineering7030091 · Cited by 105 · cited 1×
“directly delivered SALL4-siRNA to HCC cells using a lipoprotein-like scaffold which resulted in inhibition of HCC tumor growth in vivo [102].”
MethodJin, B., Wang, W., Meng, X.-X., Du, G., Li, J., Zhang, S.-Z., Zhou, B.-H., & Fu, Z.-H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2904-y · Cited by 97 · cited 1×
“Let-7 overexpression in HCC cells induces cell cycle arrest and apoptosis [92].”
BackgroundCui, W., Kong, N. R., Ma, Y., Amin, H. M., Lai, R. L., & Chai, L. (2006) · Modern Pathology · doi:10.1038/modpathol.3800694 · Cited by 92 · cited 2×
“SALL4 has a critical role in normal hematopoiesis being expressed in CD34+ hematopoietic stem cells and contributes to the maintaining of self-renewal ability and pluripotency of these cells [34].”
BackgroundSelf-citationLoss of the human polycomb group protein BMI1 promotes cancer-specific cell death
LIU, L.-M., Andrews, L. G., & Tollefsbol, T. O. (2006) · Oncogene · doi:10.1038/sj.onc.1209454 · Cited by 88 · cited 1×
“Bmi-1 drives its oncogenic role through activation of telomerase reverse transcriptase, thus inducing telomerase activity and also promoting cell cycle progression from G1 to S phase [42,43].”
BackgroundSALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway
Böhm, J., Sustmann, C., Wilhelm, C., & Kohlhase, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.124 · Cited by 84 · cited 2×
“WNT signaling also modulates SALL4 expression through T-cell factor/lymphoid enhancer factor (TCF/LEF) sequence in the promoter of the gene [14].”
BackgroundWatanabe (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.929 · Cited by 82
Overexpression of SALL4 in lung cancer and its importance in cell proliferation
Watanabe, N. (2011) · Oncology Reports · doi:10.3892/or.2011.1374 · Cited by 78
SALL4 as a new biomarker for early colorectal cancers
Khales, S. A., Abbaszadegan, M. R., Abdollahi, A., Raeisossadati, R., Tousi, M. F., & Forghanifard, M. M. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1808-y · Cited by 74
Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4
He, J., Zhang, W., Zhou, Q., Zhao, T., Song, Y., Chai, L., & Li, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.008 · Cited by 73 · cited 2×
“MiR-107 directly targets SALL4 and induces apoptosis in glioma cells both in vitro and in vivo [29].”
BackgroundSelf-citationTargeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide
Liu, B. H., Jobichen, C., Chia, C. S. B., Chan, T. H. M., Tang, J. P., Chung, T. X. Y., Li, J., Poulsen, A., Hung, A. W., Koh-Stenta, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801253115 · Cited by 67 · cited 2×
“Further optimization of this peptide led to the discovery of FFW, a pre-clinical prototype, and an SALL4/RBBP4 inhibitor that can induce apoptosis in cancer cells and hindrance of formation of xenograft in mice [88].”
BackgroundSelf-citationGao, C., Dimitrov, T., Yong, K. J., Tatetsu, H., Jeong, H.-W., Luo, H. R., Bradner, J. E., Tenen, D. G., & Chai, L. (2013) · Blood · doi:10.1182/blood-2012-04-424275 · Cited by 65 · cited 1×
“For instance, the interaction of SALL4/HDAC and SALL4/DNMT1 happens through 174 amino acids at N-terminal of the protein and needs to be further mapped as in the cases of SALL4 and RB Binding Protein 4 (RBBP4) interaction [87,88].”
BackgroundSelf-citationJeong, H.-W., Cui, W., Yang, Y., Lu, J., He, J., Li, A., Song, D., Guo, Y., Liu, B. H., & Chai, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018372 · Cited by 65 · cited 1×
“Moreover, SALL4 induces expression of another ABC transporter gene named ABCG2 indirectly which both are involved in drug sequestration [49,50].”
BackgroundSelf-citationTan, J. L., Li, F., Yeo, J. Z., Yong, K. J., Bassal, M. A., Ng, G. H., Lee, M. Y., Leong, C. Y., Tan, H. K., Wu, C.-S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.022 · Cited by 64
Self-citationSweetman, D., Smith, T., Farrell, E. R., Chantry, A., & Münsterberg, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209066200 · Cited by 63 · cited 1×
“region at N-terminal of the protein which is necessary for formation of dimer structures with SALL family members [9].”
BackgroundmiR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma
Chen, L., Zhang, N.-N., Ren, X.-Q., He, J., & Li, Y. (2018) · Molecules · doi:10.3390/molecules23112938 · Cited by 60
SALL4 is a key transcription regulator in normal human hematopoiesis
Gao, C., Kong, N. R., Li, A., Tatetu, H., Ueno, S., Yang, Y., He, J., Yang, J., Ma, Y., Kao, G. S., et al. (2013) · Transfusion · doi:10.1111/j.1537-2995.2012.03888.x · Cited by 58 · cited 1×
“Immunoprecipitation followed by microarray determined that SALL4 directly regulates key hematopoietic differentiation genes such as CD34, Runt-Related Transcription Factor 1 (RUNX1), HOXA9, and PTEN in CD34+ bone marrow cells [35].”
BackgroundSelf-citationSALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
Sun, B., Xu, L., Bi, W., & Ou, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042053 · Cited by 58 · cited 1×
“The functional association of SALL4 with cancer incidence, progression, and metastasis suggests that SALL4-targeting could be effective in eradicating cancer cells [85].”
BackgroundDemethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy
Liu, Y.-C., Kwon, J., Fabiani, E., Xiao, Z., Liu, Y. V., Follo, M. Y., Liu, J., Huang, H., Gao, C., Liu, J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2119771 · Cited by 57 · cited 1×
“It has been demonstrated that hypomethylating agents (HMA) which are currently used to treat various types of cancers, activate SALL4 through DNA demethylation as a probable side effect [18].”
BackgroundSelf-citationZinc finger protein SALL4 functions through an AT-rich motif to regulate gene expression
Kong, N. R., Bassal, M. A., Tan, H. K., Kurland, J. V., Yong, K. J., Young, J. J., Yang, Y., Li, F., Lee, J. D., Liu, Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108574 · Cited by 56
Self-citationA SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis
Li, A., Yang, Y., Gao, C., Lu, J., Jeong, H.-W., Liu, B. H., Tang, P., Yao, X., Neuberg, D., Huang, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62891 · Cited by 48 · cited 1×
“SALL4/MLL complex induces histone methylation marks H3K4 and H3K79 and also recruits RNA polymerase II at transcription start site of the HOXA9 gene, resulting in overexpression of this gene [47].”
BackgroundSelf-citationDien Bard, J., Gelebart, P., Amin, H. M., Young, L. C., Ma, Y., & Lai, R. (2009) · The FASEB Journal · doi:10.1096/fj.08-117721 · Cited by 45
SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway
Liu, C., Wu, H., Li, Y., Shen, L., Yu, R., Yin, H., Sun, T., Sun, C., Zhou, Y., & Du, Z. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2589-3 · Cited by 45 · cited 1×
“Phosphatase and tensin homolog (PTEN) that is an important tumor suppressor gene and blocks Phosphatidylinositol-3-Kinase/Protein Kinase B signaling (PI3K/AKT) is a downstream target of SALL4 [19,20].”
BackgroundSALL4 controls cell fate in response to DNA base composition
Pantier, R., Chhatbar, K., Quante, T., Skourti-Stathaki, K., Cholewa-Waclaw, J., Alston, G., Alexander-Howden, B., Lee, H. Y., Cook, A. G., Spruijt, C. G., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.11.046 · Cited by 45
Han, S.-X., Wang, J.-L., Guo, X.-J., He, C.-C., Ying, X., Ma, J.-L., Zhang, Y.-Y., Zhao, Q., & Zhu, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/262385 · Cited by 42
Importance of SALL4 in the development and prognosis of hepatocellular carcinoma
Yin, F., Han, X., Yao, S.-K., Wang, X.-L., & Yang, H.-C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2837 · Cited by 42 · cited 1×
“In addition, it is shown that patients with higher expression of SALL4 and α-fetoprotein have a worse prognosis than patients lacking these biomarkers [55].”
BackgroundSALL4 ‐ KHDRBS3 network enhances stemness by modulating CD 44 splicing in basal‐like breast cancer
Matsumoto, Y., Itou, J., Sato, F., & Toi, M. (2018) · Cancer Medicine · doi:10.1002/cam4.1296 · Cited by 42 · cited 1×
“The basal-like breast cancer cells express high levels of SALL4 through which the alternative splicing of CD44 is modulated [76].”
BackgroundUpregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer
Du, W., Ni, L., Liu, B., Wei, Y., Lv, Y., Qiang, S., Dong, J., & Liu, X. (2018) · Oncogenesis · doi:10.1038/s41389-018-0045-7 · Cited by 42
Targeting SALL4 by entinostat in lung cancer
Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12251 · Cited by 41 · cited 2×
“More experimental studies showed that SALL4-high lung cancer cells are more vulnerable to Entinostat treatment [83].”
BackgroundSelf-citationManeiro, M., Vita, E. D., Conole, D., Kounde, C. S., Zhang, Q., & Tate, E. W. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.002 · Cited by 41 · cited 1×
“Proteolysis-targeting chimaeras (PROTACs) and molecular glues induce the interaction of the target protein with E3 ubiquitin ligases and subsequent degradation of the protein through proteasome [106].”
BackgroundDissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia
Lu, J., Ma, Y., Kong, N., Alipio, Z., Gao, C., Krause, D. S., Silberstein, L. E., & Chai, L. (2011) · Leukemia · doi:10.1038/leu.2011.65 · Cited by 40 · cited 1×
“CD34+/CD38+ cells that are suggested to be the leukemia-initiating cells (LIC) and promote progression of CML to blast crisis also demonstrate high expression of SALL4 [37].”
BackgroundSelf-citationItou, J., Matsumoto, Y., Yoshikawa, K., & Toi, M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.07.049 · Cited by 40
Fan, H., Cui, Z., Zhang, H., Mani, S. K. K., Diab, A., Lefrançois, L., Farés, N., Merle, P., & ANDRISANI, O. M. (2016) · Oncogene · doi:10.1038/onc.2016.399 · Cited by 40 · cited 1×
“This group further shows that this CpG island is within the binding site of OCT4 and STAT3, and demethylation augments occupancy of these sites by transcription factors and recruitment of chromatin remodeling Brahmarelated gene-1 (BRG1), which all result in SALL4 re-activation [65].”
BackgroundOncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis
Nicolè, L., Sanavia, T., Veronese, N., Cappellesso, R., Luchini, C., Dabrilli, P., & Fassina, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14952 · Cited by 39 · cited 1×
“These data indicate that SALL4 is associated with a poor survival rate and suggests it as a potential biomarker of cancer prognosis [6].”
BackgroundSALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis
Yang, J. (2018) · Biomarker Research · doi:10.1186/s40364-017-0115-6 · Cited by 39 · cited 2×
“Nevertheless, it is shown that SALL4 is over activated in hematologic malignancies and is linked to worse outcome in patients [4].”
BackgroundHupfeld, T., Chapuy, B., Schrader, V., Beutler, M., Veltkamp, C., Koch, R., Cameron, S., Aung, T., Haase, D., LaRosee, P., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12246 · Cited by 37 · cited 1×
“It is demonstrated that resistant to tyrosine kinase inhibitors such as imatinib, dasatinib, and nilotinib is associated with augmented levels of SALL4 and ABCA3 leading to formation of drug-resistance leukemic cell lines [51].”
BackgroundSignificance of SALL4 as a drug-resistant factor in lung cancer
Yanagihara, N., Kobayashi, D., Kuribayashi, K., Tanaka, M., Hasegawa, T., & Watanabe, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2866 · Cited by 36
Practice-changing updates in the adjuvant and metastatic setting
Puccini, A., & Lenz, H. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.185 · Cited by 36
Shi, D.-M., Shi, X.-L., Xing, K.-L., Zhou, H.-X., Lu, L.-L., & Wu, W.-Z. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109650 · Cited by 36 · cited 1×
“Brg1 which enhances expression of SALL4 by binding to its promoter is potentially inhibited by miR-296-5p [97].”
BackgroundShuai, X., Zhou, D., Shen, T., Wu, Y., Zhang, J., Wang, X., & Li, Q. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.06.006 · Cited by 35
YUE, X., Xiao, L., Yang, Y., Liu, W., ZHANG, K., Shi, G.-Y., Zhou, H., Geng, J., NING, X., Wu, J., et al. (2015) · Neoplasma · doi:10.4149/neo_2015_119 · Cited by 35
Ueno, S., Lu, J., He, J., Li, A., Zhang, X., Ritz, J., Silberstein, L. E., & Chai, L. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.01.005 · Cited by 33 · cited 1×
“Moreover, treatment of B-ALL cells with methylation inhibitors leads to demethylation of SALL4 regulatory regions and its overexpression [26].”
BackgroundSelf-citationExpression and clinical significance of SALL4 and β-catenin in colorectal cancer
Hao, L., Zhao, Y., Wang, Z., Yin, H., Zhang, X., He, T., Song, S., Sun, S., Wang, B., Li, Z., et al. (2016) · Journal of Molecular Histology · doi:10.1007/s10735-016-9656-5 · Cited by 33 · cited 2×
“showed that SALL4 and β-catenin are positively correlated and interact with each other in CRC cells [67].”
BackgroundStem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
Wang, F., Guo, Y., Chen, Q., Yang, Z., Ning, N., Zhang, Y., Xu, Y., Xu, X., Tong, C., Chai, L., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-73 · Cited by 32 · cited 1×
“Our findings showed that the level of SALL4 expression is positively correlated with karyotype abnormalities, poor survival, and an increased risk of MDS to AML transformation [39,40].”
BackgroundSelf-citationChen, Y., Li, Z.-Z., Ye, Y., Xu, F., Niu, R., Zhang, H., Zhang, Y., Liu, Y., & Han, B. (2016) · BMC Molecular Biology · doi:10.1186/s12867-016-0055-y · Cited by 31 · cited 1×
“High expression of SALL4 also is linked to chemo-resistance of breast cancer cells [75].”
BackgroundPseudogene-mediated DNA demethylation leads to oncogene activation
Kwon, J., Liu, Y. V., Gao, C., Bassal, M. A., Jones, A. I., Yang, J., Chen, Z., Li, Y., Yang, H. H., Chen, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg1695 · Cited by 30
Self-citationTargeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy
Yang, J., Gao, C., Liu, M., Liu, Y., Kwon, J., Qi, J., Tian, X., Stein, A. J., Liu, Y. V., Kong, N. R., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0030 · Cited by 29 · cited 1×
“MiRNA sequencing after Entinostat treatment showed that this drug downregulates SALL4 by up-regulation of miR-205 [16].”
BackgroundSelf-citationSALL 4 immunohistochemistry in non‐small‐cell lung carcinomas
Fujimoto, M., Sumiyoshi, S., Yoshizawa, A., Sonobe, M., Kobayashi, M., Moriyoshi, K., Kido, A., Tanaka, C., Koyanagi, I., Date, H., et al. (2013) · Histopathology · doi:10.1111/his.12241 · Cited by 26 · cited 1×
“The competence of SALL4 as an immunohistochemical marker for high-grade lung adenocarcinomas with fetal-like morphology is also validated [81].”
BackgroundAberrant hypomethylation of SALL4 gene in patients with myelodysplastic syndrome
Lin, J., Qian, J., Yao, D., Qian, W., Yang, J. C., Wang, C., Chai, H., Ma, J., Deng, Z., Li, Y., et al. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.10.014 · Cited by 24 · cited 2×
“On the other hand, methylation-specific PCR (MSP) has validated aberrant hypomethylation of SALL4 promoter in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients [15,27].”
BackgroundThe differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia
Shen, Q., Liu, S., Hu, J., Chen, S., Yang, L., Li, B., Wu, X., Ma, Y., Yang, J., Ma, Y., et al. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-42 · Cited by 24 · cited 2×
“Chromatin-immunoprecipitation (ChIP) along with electrophoretic mobility shift assay (EMS) determined biding of SALL4 to the promoter of ATP-binding cassette(ABC)A3, resulting in over expression of this ABC protein and drug-resistance in these cells [46].”
BackgroundWang, H., Kohashi, K., Yoshizumi, T., Okumura, Y., Tanaka, Y., Shimokawa, M., Iwasaki, T., Aishima, S., Maehara, Y., & Oda, Y. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.03.007 · Cited by 24
Inhibition of SALL4 suppresses carcinogenesis of colorectal cancer via regulating Gli1 expression.
Cheng, J., Deng, R., Wu, C., Zhang, P., Wu, K., Shi, L., Liu, X., Bai, J., Deng, M., Gao, J., et al. (2015) · PubMed · Cited by 24
Ma, J., Qian, J., Lin, J., Qian, W., Yang, J. C., Wang, C., Chai, H., Li, Y., Chen, Q., & Qian, Z. Y. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.11.018 · Cited by 21 · cited 2×
“On the other hand, methylation-specific PCR (MSP) has validated aberrant hypomethylation of SALL4 promoter in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients [15,27].”
BackgroundItou, J., Tanaka, S., Li, W., Iida, A., Sehara‐Fujisawa, A., Sato, F., & Toi, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.012 · Cited by 21 · cited 1×
“In basal-like breast cancer cells, SALL4 upregulates expression of cell migration related integrin genes ITGA6 and ITGB1 [77].”
BackgroundMicroRNA‑219 exerts a tumor suppressive role in glioma via targeting Sal‑like protein 4
Jiang, B., Li, M., Ji, F., & Nie, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5292 · Cited by 21
Chang, S., Sun, G., Zhang, D., Li, Q., Wan, Y., Zhou, X., Lu, Q., Han, X., Chen, X., Xing, T., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02789-z · Cited by 21 · cited 1×
“MiR-3622a-3p interacts with SALL4 and subsequently suppresses stemness features of CRC cells [70].”
BackgroundLu, J., Jeong, H.-W., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009) · PLoS ONE · doi:10.1371/annotation/e0bd3a57-1ce4-4eaf-83de-034d39cac787 · Cited by 20
Self-citationZhou, Y., Liu, Y., Hu, C., & Jiang, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2775 · Cited by 20
Tanaka, Y., Aishima, S., Kohashi, K., Okumura, Y., Wang, H., Hida, T., Kotoh, K., Shirabe, K., Maehara, Y., Takayanagi, R., et al. (2015) · Histopathology · doi:10.1111/his.12806 · Cited by 19 · cited 1×
“In another study, the association of SALL4 immunoreactivity with α-fetoprotein and E-Cadherin is reported [64].”
BackgroundExploiting the DepMap cancer dependency data using the depmap R package
Killian, T., & Gatto, L. (2021) · F1000Research · doi:10.12688/f1000research.52811.1 · Cited by 19
Stem Cell Gene SALL4 in Aggressive Hepatocellular Carcinoma: A Cancer Stem Cell-Specific Target?
Yakaboski, E., Jares, A., & Ma, Y. (2013) · Hepatology · doi:10.1002/hep.26956 · Cited by 19
Liu, L., Liu, L., Leung, L.-H., Cooney, A. J., Chen, C., Rosengart, T. K., Ma, Y., & Yang, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.634790 · Cited by 19 · cited 1×
“It is shown that the combination of ATRA and SALL4 inhibitors has a strong restraining effect on AML cells [48].”
BackgroundThe diagnostic and prognostic value of SALL 4 in hepatoblastoma
Zhou, S., Venkatramani, R., Gomulia, E., Shillingford, N., & Wang, L. L. (2016) · Histopathology · doi:10.1111/his.13005 · Cited by 19 · cited 1×
“Indeed, the high expression of SALL4 is shown to be significantly correlated with decreased overall survival in hepatoblastoma samples [56].”
BackgroundEffect of SALL4 on the Proliferation, Invasion and Apoptosis of Breast Cancer Cells
Liu, C., Yao, F., Mao, X., Li, W., & Chen, H. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820980074 · Cited by 19 · cited 3×
“It is demonstrated that the degree of SALL4 expression is significantly related to tumor size and invasion to lymph nodes in breast cancer patients [31].”
BackgroundExpression and clinical significance of SALL4 and LGR5 in patients with lung cancer
GAUTAM, A. K., Wang, C., Zeng, J., Wang, J., Lu, J., Wei, J., Huang, G., Mo, B.-F., Luo, M., & Mo, B. (2015) · Oncology Letters · doi:10.3892/ol.2015.3772 · Cited by 18 · cited 1×
“SALL4 aberrant expression is observed in lung cancer patients with poor survival and it is shown to be a good diagnostic marker with 88% sensitivity and 100% specificity in lung cancer patients [79].”
BackgroundLi, J., Zhang, Y., Tao, X., You, Q., Zheng, T., He, Z., & Ou, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-7939 · Cited by 18 · cited 1×
“SALL4 knock down resulted in down regulation of Cyclin B, Cyclin E, and Cyclin D1 and subsequent cell cycle arrest in the G0/G1 [82].”
BackgroundLeukemic survival factor SALL4 contributes to defective DNA damage repair
Wang, F., Gao, C., Lu, J., Tatetsu, H., Williams, D. A., Müller, L. U., Cui, W., & Chai, L. (2016) · Oncogene · doi:10.1038/onc.2016.146 · Cited by 17 · cited 1×
“In addition, it was demonstrated that the anti-apoptotic protein Bcl2 is upregulated in SALL4 transgenic mice, causing more cancer cell survival [41].”
BackgroundSelf-citationWu, H., Liu, C., Xiao-xia, F., Wang, H., & Zhou, L. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170204 · Cited by 17 · cited 1×
“7% specificity for SALL4 in serum from CRC patients [68].”
BackgroundKnockdown of SALL4 overcomes cisplatin-resistance through AKT/mTOR signaling in lung cancer cells.
Jiang, G., & Liu, C. (2018) · PubMed · Cited by 16
Prognostic value of let-7 in lung cancer: systematic review and meta-analysis
Shen, C. H., Li, J., & Che, G. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-1240 · Cited by 16 · cited 1×
“Moreover, low Let-7 expression is shown to be a predictor of poor prognosis in lung cancer patients [93].”
BackgroundIdentification of the nuclear localization signal of SALL4B, a stem cell transcription factor
Wu, M., Yang, F., Ren, Z., Jiang, Y., Ma, Y., Chen, C., & Dai, W. H. (2014) · Cell Cycle · doi:10.4161/cc.28418 · Cited by 15 · cited 1×
“As a transcription regulatory factor, SALL4 has a nuclear localization signal at amino acids 64–67 [10].”
BackgroundSALL4 and microRNA: The Role of Let-7
Liu, J., Sauer, M. A., Hussein, S. G., Yang, J., Tenen, D. G., & Chai, L. (2021) · Genes · doi:10.3390/genes12091301 · Cited by 14 · cited 2×
“There are several other miRNAs that their regulatory effect on SALL4 has been identified, which have extensively been discussed in our previous review article [30].”
BackgroundSelf-citationWang, P., Zhang, J. D., Wu, F., Ye, X., Sharon, D. M., Hitt, M., McMullen, T. P. W., Hegazy, S. A., Gélébart, P., Yang, J., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.06.005 · Cited by 13 · cited 1×
“SALL4 is also highly expressed in anaplastic large cell lymphoma and knock down of the gene has similar effects in restriction of cell-cycle progression and induction of apoptosis [36].”
BackgroundKnockdown of sal‐like 4 expression by small interfering RNA induces apoptosis in breast cancer cells
Hesari, A., Anoshiravani, A. A., Talebi, S., Noruzi, S., Mohammadi, R., Salarinia, R., Zare, R., & Ghasemi, F. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28214 · Cited by 10 · cited 1×
“Knock down of SALL4 by siRNA is shown to induce apoptosis in colorectal and breast cancer cells [72,101].”
BackgroundWang, J., Huang, J., Ma, Q., & Liu, G. (2019) · Cancer Management and Research · doi:10.2147/cmar.s199968 · Cited by 9 · cited 1×
“Moreover, as a potential early diagnostic and prognostic biomarker, SALL4 shows a considerably high correlation with parameters of contrastenhanced ultrasonography in patients with HCC [62].”
BackgroundDi, C., Sun, J. Y., Zhang, H., Zhou, P., & Kong, J. (2018) · PubMed · Cited by 9
Chen, K. Q., Anderson, A. M., Kawakami, H., Kim, J. S., Barrett, J., & Kawakami, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267273 · Cited by 8 · cited 1×
“Knock down studies show its prominent role in different stages of fetal development [2] and mutation in the SALL4 gene is the cause of an autosomal dominant syndrome named Okihiro that mainly affects eyes, bones of arms and hands, heart, and renal system [3].”
BackgroundKnockdown of Sal‐like 4 expression by siRNA induces apoptosis in colorectal cancer
Hesari, A., Rajab, S., Rezaei, M., Basam, M., Golmohamadi, S., & Ghasemi, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28433 · Cited by 6 · cited 3×
“Silencing of this gene dramatically reduced resistance of CRC cells to fluorouracil and oxaliplatin [71] and lowered the level of anti-apoptotic BCL2 protein in CRC and other types of cancer [72].”
BackgroundOhadi, F., Rahgozar, S., & Ghodousi, E. S. (2020) · Cancer Management and Research · doi:10.2147/cmar.s240469 · Cited by 6 · cited 1×
“Moreover, SALL4 induces expression of another ABC transporter gene named ABCG2 indirectly which both are involved in drug sequestration [49,50].”
BackgroundMiRNA-98 inhibits ovarian carcinoma cell proliferation, migration and invasion via targeting SALL4
Wang, Z., Han, Y., Xia, X., Jiang, C., Guo, H., & Guan, Y. (2021) · Minerva Medica · doi:10.23736/s0026-4806.19.06179-2 · Cited by 6
Cited by
Steinebach, C., Bricelj, A., Murgai, A., Sosič, I., Bischof, L., Ng, Y. L. D., Heim, C., Maiwald, S. A., Proj, M., Voget, R., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00851 · Cited by 60
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy
Wang, W., Liu, W., Chen, Q., Yuan, Y., & Wang, P. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.11.002 · Cited by 51
Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma
Liu, J., Park, K., Shen, Z., Lee, H. M., Geetha, P., Pakyari, M., & Chai, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285370 · Cited by 25
“Another promising TF target is SALL4, a TF involved in cell renewal and growth during development (124).”
BackgroundSelf-citationRole of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway
Pattanayak, B., Lameirinhas, A., Torres‐Ruiz, S., Burgués, O., Rovira, A., Martínez, M. T., Tapia, M., Zazo, S., Albanell, J., Rojo, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113292 · Cited by 16
Cancer stem cell biomarkers and related signalling pathways
Wang, Z., Li, R. Q., Yang, G., & Wang, Y. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2295222 · Cited by 15
“the human homolog of the Drosophila salt (sal) homeostasis gene, SAll4, encodes a c2H2 zinc finger transcription factor (tF) [93].”
Background
Metadata
- Authors
- Moein, S., Tenen, D. G., Amabile, G., & Chai, L.
- Affiliations
- Cancer Science Institute of Singapore (SG)
- Harvard University (US)
- Believer Pharmaceuticals, Inc., Wilmington, DE 19801, USA
- Brigham and Women's Hospital (US)
- Corresponding author
- Tenen, Daniel G.
- Amabile, Giovanni
- Chai, Li
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-08-20
- Volume
- 11
- Issue
- 16
- Pages
- 2601
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9406946
- OpenAlex
- W4292549048
- Cited by
- 35
- References
- 116
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 3
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Health (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
- NIH/NHLBI (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
- Singapore Ministry of Health’s National Medical Research Council (Singapore Translational Research (STaR) Investigator Award) (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
- Xiu research fund (R35CA197697, P01HL131477-01A1, STaR18nov-0002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Keywords
- SALL4, oncogenes, cancer therapy, therapeutic target, transcription factors, epigenetic regulation, gene repression, stem cell pluripotency, metastasis, drug design
- MeSH terms
- Adult, Gene Expression Regulation, Humans, Neoplasms, Stem Cells, Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.